Integrative multi-omics identifies a glycosylation-based prognostic framework and nominates ALG3 for targeted therapy in bladder cancer. Feng W, He W. Discov Oncol 2026 Jun 7. doi: 10.1007/s12672-026-05387.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Feng W, He W. Integrative multi-omics identifies a glycosylation-based prognostic framework and nominates ALG3 for targeted therapy in bladder cancer. Discov Oncol 2026 Jun 7. doi: 10.1007/s12672-026-05387.
PMID: 42251607